|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.27 USD | +3.63% |
|
+13.56% | -6.76% |
| 03-11 | Legend Biotech Shares Likely to Rebound in 2026 on Robust Fundamentals, RBC Says | MT |
| 03-11 | RBC Cuts Price Target on Legend Biotech to $62 From $66, Keeps Outperform Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 20.31 | 23.7 | 27.71 |
| Spread/Res. | -0.20% | -14.47% | -26.85% |
| Spread/Supp. | +9.33% | +21.74% | +18.54% |
| Support | 18.54 | 16.65 | 17.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LEGN Stock
- Charts Legend Biotech Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition